Patient-centered medical homes are valuable because they allow insurers to look at the cost of all of the patient’s treatments, services, and physicians throughout the continuum of care, explained Kim Eason, manager at Horizon Blue Cross Blue Shield of NJ.
Patient-centered medical homes are valuable because they allow insurers to look at the cost of all of the patient’s treatments, services, and physicians throughout the continuum of care, explained Kim Eason, manager at Horizon Blue Cross Blue Shield of NJ.
Transcript (slightly modified)
How can innovative programs like patient-centered medical homes improve cancer outcomes and care quality, while managing costs?
So the patient-centered medical home looks at the total cost of care and all the types of services and physicians that a patient may be seeing. Horizon was one of the first in the state of New Jersey, we partnered with the New Jersey American Academy of Family Physicians and 8 primary practices under our healthcare innovations division about 6 years ago to look at a patient-centered medical home model.
Since we were on the forefront with that, we understand that putting those integral pieces together and then looking at the cost along the continuum of care allows for that patient-centered medical home, or patient-centered medical neighborhood, to work. Because you’re bringing everyone together, and you’re looking at all the services that the patient’s having, and all of the physicians that can impact them as they’re going through their care treatments and along that care continuum.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More